Latigo saddles up with $150M to spur non-opioid pain drugs through the clinic

Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance its pipeline of non-opioid pain management drugs.

Mar 17, 2025 - 10:13
 0
Latigo saddles up with $150M to spur non-opioid pain drugs through the clinic
Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance its pipeline of non-opioid pain management drugs.